Efforts towards this have identified regulation of CD155, a checkpoint ligand for TIGIT, by FAK, and FAK expression is positively associated with TIGIT checkpoint ligands in human high grade serous ovarian cancer [39]. The gene discussed is TIGIT; the disease is ovarian serous adenocarcinoma.